Funding for this research was provided by:
The study was unconditionally supported by Neopharmed Gentili
Received: 23 December 2021
Accepted: 5 April 2022
First Online: 26 April 2022
Change Date: 13 May 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/S12933-022-01515-7
: The study conforms to the ethical guidelines of the 1975 Declaration of Helsinki, completely anonymized data were analyzed and based on National and International regulations, a waiver was applied to the requirement for patients' informed consent.
: Not applicable.
: MLM received lecture or advisory fees or grant support from Mylan, SlaPharma, Servier, Lilly, MSD, Novo Nordisk, and was unconditionally supported by LatoC Srl for conducting the analyses of the data of the current work and writing the manuscript. OL received speaker or advisory board fees from Eli-Lilly and NovoNordisk, research grants from Astra Zeneca. EM none. AG has received honoraria or consulting fees from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, MSD, and Sanofi, and research funding from AstraZeneca. AA received research grants, lecture or advisory board fees from Merck Sharp & Dome, AstraZeneca, Novartis, Boeringher-Ingelheim, Sanofi, Mediolanum, Janssen, Novo Nordisk, Lilly, Servier, and Takeda.